Process Validation Report
Process Validation Report
of 17
EFFECTIVE DATE
1. SUMMARY
The purpose of research was to study prospective validation of LamaVet Tick
Grease dosage formulation. Quality cannot be adequately
assured by in-process and finished inspections and testing but it
should be built in to the manufacturing process. These processes
should be controlled in order that the finished product meets all
quality specifications. Therefore, building of quality requires careful
attention to a number of factors, such as the selection of materials, product and process
design, control variables, in process control and finished product testing.
2. INTRODUCTION
TITLE SIGNATURE DATE
PREPARED BY Production Manager
APPROVED Technical Manager
Page 2
of 17
EFFECTIVE DATE
EFFECTIVE DATE
3.3 Manufacturers:
Agricura (Pvt) Ltd
(i) Chlorfenvinphos
(a) Description
Chlorfenvinphos is an
organophosphorus insecticide and acaricide used
in the control of flies, fleas, mites and moths in and around agricultural
buildings, pastures, and potato crops.
Chlorfenvinphos is also widely used
in external parasiticide
formulations for use on cattle, sheep, deer, goats, horses and dogs.
Technical chlorfenvinphos (comprised of the sum of
E- and Z-isomers) has a minimum
purity of 900 g/L. Typically, the ratio of isomers Z:E is
8.6:1 in the technical material, with both the cis and the trans isomers
having insecticidal activity. Whilst the potency of the
isomers varies from species to
species, the trans isomer is usually the more active one.
TITLE SIGNATURE DATE
PREPARED BY Production Manager
APPROVED Technical Manager
Page 4
of 17
EFFECTIVE DATE
EFFECTIVE DATE
(ii) Deltamethrin
(a) Description
Deltamethrin is a synthetic pyrethroid
insecticide that is largely used in
structural pest control. A potent insecticide, effective by contact and
ingestion against a wide range of pests. Crop
protection uses include: Coleoptera,
Heteroptera, Homoptera, Lepidoptera and Thysanoptera in
cereals, citrus, cotton, grapes, maize, oilseed rape, soya beans, top fruit
and vegetables. It controls Acrididae, and is
recommended against locusts. Soil
surface sprays control Noctuidae. It is used against indoor
crawling and flying insects, and pests of stored grain and timber. Dip
or spray, and pour-on applications give good
control of Muscidae, Tabanidae,
Ixodidae and other Acari on cattle, sheep and pigs, etc.
EFFECTIVE DATE
Construction, Asphalting, Water Proofing Solutions & Manufacturers of Adhesives, Sealants, Coatings and related glues.
4- Finished Product Specification & Finished Product Analysis and Acceptance Criteria for LamaVet Tick Grease:
Construction, Asphalting, Water Proofing Solutions & Manufacturers of Adhesives, Sealants, Coatings and related glues.
Following raw materials are used in the manufacturing of sucralfate oral suspension. All the
raw materials were tested in the quality control department and individual certificate of analysis is
generated and it assures that all the materials will complies with specifications.
Construction, Asphalting, Water Proofing Solutions & Manufacturers of Adhesives, Sealants, Coatings and related glues.
6. MANUFACTURING PROCESS
All the APIs along with the excipients were mixed in the SS manufacturing tank and after mixing the
suspension is transferred into #60 mesh in order to ϐilter the suspension. After ϐiltration decartoning,
washing and drying of empty PET bottles were done and the ϐilling and sealing operation were
performed. The steps in the manufacturing are shown in Figure 1 and packing is shown in Figure 2.
Construction, Asphalting, Water Proofing Solutions & Manufacturers of Adhesives, Sealants, Coatings and related glues.
Construction, Asphalting, Water Proofing Solutions & Manufacturers of Adhesives, Sealants, Coatings and related glues.
The critical process variables were tested for the manufacturing of sucralfate oral suspension and
results were shown in theTable 1. All the process parameters were performed and the results were
shown in the Table 2. Sampling locations depicted in Table 3. Environmental monitoring of
manufacturing area was done and the results were shown in the Table 4. Yield statement of bulk
suspension is given in Table 5. The bottle washing details were given in Table 6. Empty bottle
physical appearance test is done and it is free from ϐibred and coloured particles. The parameters at
the ϐilling and sealing operation were determined and results are shown in Table 7. Process veritable
results were shown in Table 8. In-process product analysis during ϐilling and sealing operation were
determined and results were shown in Table 9. Environmental monitoring of ϐilling and sealing area
is monitored and results were given inTable 10. Finished product analysis of sucralfate oral
suspension results were shown in Table 11. Yield statement for ϐinished product is shown in Table
12.
The process validation was started at the qualification of equipment all the equipment was
qualified at the time of process validation. Environmental condition monitoring of
manufacturing area is critical process parameter for process validation. In environmental
monitoring critical parameter like, temperature, relative humidity, and differential pressure,
viable or non-viable particles are generally monitored. The maximum and minimum
temperature was found to be 22.44ºC and 19.21ºC respectively in different processing area.
The maximum and minimum relative humidity% was found 27.50% and 18.23%
respectively in different processing area. The maximum and minimum differential pressure
was found to be 3.4 mm of WC and 1.8 mm of WC respectively depends on different
processing area. The viable particles were not found during observation. The maximum non
TITLE SIGNATURE DATE
PREPARED BY Production Manager
APPROVED Technical Manager
ADHERECHEM
Construction, Asphalting, Water Proofing Solutions & Manufacturers of Adhesives, Sealants, Coatings and related glues.
viable particles of ≥0.5µ were found to be 536 and 1645 per m3 respectively in sterile filling
area and area adjacent to sterile area. Similarly, the maximum non viable particles of ≥5.0µ
were found to be 5 and 329 per m3 respectively in sterile filling area and area adjacent to
sterile area. The visible and non visible particulate matter was checked during vial washing,
sterilization and filling stages, the particulate matter was found to be as per acceptance
criteria. During vial filling and stoppering the weight variation and content uniformity of
dosage unit was also calculated / checked. The result was found under acceptance criteria.
Sealing integrity test was performed after vial sealing with the help of sealing integrity test
apparatus no defects was observed in this test. Analytical test and sterility test of finished
product was performed by quality control and microbiology department both test were
complies. All about the calculation the batch yield of three consecutive batches were found
to be 95.14%, 95.67% and 95.53% respectively.
So the data of all three batches were complying with its acceptance criteria. Hence the
product can be successfully manufactured at the commercial scale and the sterile
manufacturing process is validated.
Where the result obtained show significant deviations from those expected, the regulatory
authorities need to be informed immediately. In such cases corrective action should be
proposed and any changes proposed in the manufacturing process should receive prior
regulatory approval by way of variation.
The blending was performed and the samples at the designated locations were drawn after 20, 40 and
60minutes of blending for determination of the API content. The content, appearance, specific
gravity, values and emulsifiability meet the acceptance criteria at the all the 3 blending intervals.
From the analytical results it is clear that the API distribution pattern in the blend is almost
homogeneous.
The distribution of the Deltamethrin and Chlorfenvinphos is well acceptable as per the
predetermined specification at all the intervals of blending as shown by the samples analysed, after
60 minutes results show more closer homogeneity of API distribution with other excipient of
blend.
Construction, Asphalting, Water Proofing Solutions & Manufacturers of Adhesives, Sealants, Coatings and related glues.
Construction, Asphalting, Water Proofing Solutions & Manufacturers of Adhesives, Sealants, Coatings and related glues.
CONCLUSIONS
The equipment used in the manufacturing of the LamaVet Tick Grease were checked for their
Installation, Operation and Performance Qualification and verified. Key variables in the preparation
of sucralfate oral suspension were selected and all the critical process variables are were found within
TITLE SIGNATURE DATE
PREPARED BY Production Manager
APPROVED Technical Manager
ADHERECHEM
Construction, Asphalting, Water Proofing Solutions & Manufacturers of Adhesives, Sealants, Coatings and related glues.
the limits. The process condition at each unit operation was established. The process parameters in the
preparation of LamaVet Tick Grease were meeting its predetermined specifications. Hence, the
process validation of LamaVet Tick Grease was performed and the process meets its predetermined
specifications and hence the product is maintaining the good quality from the first step to the final
step of validation.
Conflict of Interest
The authors declare that they have no conflict of interest for this study.
REFERENCES
1. Guidance for Industry Process Validation: General Principles and Practices, Food and Drug
AdministrationRobert A Nash and Alfred H. Wachter, Pharmaceutical Process Validation, Third
Edition,
volume 129, Marcel Dekker, Inc, New York, 2003:159-180.
2. http://www.astm.org/Standards/E1153.htm
3. https://store.pda.org/bookstore/ProductDetails.aspx?productabbreviation=43218
4. http://www.fda.gov/downloads/BiologicsBloodVaccines/
GuidanceComplianceRegulatoryInformation/Guidances/Tissue/UCM285223.pdf
5. http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=2004_register&docid=fr24no04-
9.pdf
6. http://www.iso.org/iso/iso_catalogue/catalogue_tc/catalogue_tc_browse.htm?commid=54874
7. http://www.restoresight.org/wp-content/uploads/2011/11/Medical-Standards-October-2011.pdf
8. Don Armbruster and Thomas Feldsien, Applying HACCP to pharmaceutical process Validation.
PharmaceuticalTechnology, October, 2000;24(10):170 -178.
9. Guidance for Industry Process Validation: General Principles and Practices, US FDA 2008.
10. Kathiresan K, Sreenu VS, Moorthi C, Bharath Reddy Gade, Bhagath Kumar Reddy M, Yellamula
Prathyusha and Manavalan R. Cleaning Validation of AcetaminophenTablets. International
Journal of Chemical Environmental and Pharmaceutical research. 2010;3(3):503-506.
11. Agalloco J. The validation life cycle. J ParenterSciTechnol. 1993;47(3):142-147.
12. Beckett, A. H., Stenlake, J. B. 1997. Practical Pharmaceutical Chemistry, 4th Ed, New Delhi.
New Delhi. CBS. 275-325. ISBN-13:979-8123905135.
13. Desai, L., Oza, J., Khatri, K. 2012. Prospective process validation of polyherbal cough syrup
formulation. Journal of Advanced Pharmacy Education, (4):225– 231.
14. EMA 2012. Guideline on Process Validation (Draft), Geneva, Switzerland. pages 10–11.
European Medicines Agency.
15. FDA 2011a. Guidance for industry, Process Validation: General Principles and Practice,
Maryland, USA. pages 3–4. United States Food and Drug Administration.
16. FDA 2011b. Q8 guidelines for Pharmaceutical Development (Draft), Revision 1, version 8.1,
Maryland. pages 2–3. United States Food and Drug Administration, USA.
Construction, Asphalting, Water Proofing Solutions & Manufacturers of Adhesives, Sealants, Coatings and related glues.
17. ICH harmonized tripartite guideline 2009. Q8 Guidelines for Pharmaceutical Development,
Revision 2, Geneva, Switzerland. pages 12–14. International conference on harmonisation of
technical requirements for registration of pharmaceuticals for human use.
18. Levin, M. 2006. Pharmaceutical Process Scale-U. 2nd Edition. pages 199–220, New York. Taylor
and Francis Group, CRC Press New York. ISBN: 10 #1- 57444-876-5.
19. Lloyd, R. S., Joseph, J. K., Joseph, L. G. 2007. Practical HPLC Method Development. 2nd
Edition. pages 1–20, New York. Wiley-Interscience. ISBN: 978-0- 471-00703-6.
20. Raveendranath, T. V., Kumar, K. K., Madhuri, L., Sasaikanth, K. 2010. Process validation of
Citalopram Hydro bromide tablets. International Journal of Research in Pharmaceutical and
Biomedical Sciences, 1(2):109–123.
21. Robert, A. N., Alfred, H. 2003. Pharmaceutical Process Validation. 3rd Edition, volume 129.
pages 159–180, Marcel Dekker, New York. ISBN: 0-8247- 0838-5.
22. Sethi, N. K., Hantus, S. 2016. Evaluating persistent altered mental status after status
epilepticusAuthor Responds:. Neurology: Clinical Practice, 6:8.2–9.
23. Swarbrick, J., Boyan, J. C. 2002. Encyclopedia of Pharmaceutical Technology, 2nd Edition, Vol I
Construction, Asphalting, Water Proofing Solutions & Manufacturers of Adhesives, Sealants, Coatings and related glues.
24. II. pages 2708–2709. Marcel Dekker Inc, New York. ISBN: 0-8247-2822-X.